Investor Relations

CORPORATE OVERVIEW

At Windgap Medical, we develop and commercialize combination products and drug delivery devices that simplify, automate, and accelerate the administration of complex injectables—and a better, sustainable patient experience.

Based in Boston, Massachusetts, Windgap has been creating a new frontier of pharma since it was founded in 2011. We are guided by a leadership team with over 120 years of experience and 30+ regulatory approvals for drug and/or device combination products—and we’re just getting warmed up.

Innovative Technology

Our novel dual-chamber autoinjector technology simplifies the administration of life-saving medications, ensuring accuracy, ease of use, and improved patient compliance. This technology is designed to address unmet market needs, providing a competitive edge and a substantial growth opportunity.

Windgap Innovative Technology

Strategic Partnerships

Our recent collaborations with Novo Nordisk, ALK Abelló, and more highlight our ability to form strategic alliances with industry leaders. These partnerships accelerate our development processes and expand our reach in the global healthcare market.

Partnerships in Progress

Windgap Partnership ALK Abello
Windgap Partnership Allergy Partners
Windgap Partnership University of Minnesota
Windgap Partnership Molex

Sustainable Solutions

We are driven to pioneer sustainable drug delivery solutions that help patients live life without limits. This includes innovative solutions that reduce the impact of waste, cold storage, and carbon footprints on our planet.

Windgap Sustainability

For investment inquiries, click here to contact us
or email ir@windgapmedical.com.